Merkel Cell Carcinoma (MCC)

Patients treated for Merkel cell carcinoma (MCC) face a five-year recurrence rate of 40% — markedly higher than the recurrence rates for melanoma and other skin cancers, according to research published today in JAMA Dermatology.

University of Washington School of Medicine/UW Medicine. “Patients with rare skin cancer face 40% recurrence rate.” ScienceDaily. http://www.sciencedaily.com/releases/2022/02/220223111226.htm (accessed February 24, 2022).